{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:58:15Z","timestamp":1775084295880,"version":"3.50.1"},"reference-count":35,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2019.1850","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T07:41:29Z","timestamp":1556091689000},"source":"Crossref","is-referenced-by-count":5,"title":["CD163 is a predictive biomarker for prognosis of classical Hodgkin's lymphoma in Saudi patients"],"prefix":"10.3892","author":[{"given":"Huda","family":"Al Sayed Ahmed","sequence":"first","affiliation":[{"name":"Pathology and Laboratory Services Department, Johns Hopkins Aramco Healthcare, 1709 Dhahran, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasim","family":"Raslan","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Services Department, Johns Hopkins Aramco Healthcare, 10613 Dhahran, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel","family":"Deifalla","sequence":"additional","affiliation":[{"name":"Department of Anatomy, College of Medicine and Medical Sciences, 26671 Manama, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Fathallah","sequence":"additional","affiliation":[{"name":"Department of Higher Studies, Arabian Gulf University, 26671 Manama, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"key20200713202436_b1-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.7314\/APJCP.2015.16.5.2069","article-title":"Changing trends of adult lymphoma in the kingdom of Saudi Arabia-comparison of data sources","volume":"16","author":"Rauf","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20200713202436_b2-mco-0-0-1850","unstructured":"Leukemia and Lymphoma SocietyAmerican Cancer Society Cancer Facts and Figures 2016; GLOBOCAN 2012; ClinicalTrials.govCRI grantee progress reports and other CRI grantee documents2016http:\/\/www.cancerresearch.org\/cancer-immunotherapy\/impacting-all-cancers\/lymphoma#sthash.9EkuimDH.dpuf 91November142014"},{"key":"key20200713202436_b3-mco-0-0-1850","unstructured":"Al-MadoujANEldaliAAl-ZahraniASTen year cancer incidence among nationals of the GCC statesGulf center for cancer control and prevention, king faisal specialist hospital and research center2011http:\/\/www.moh.gov.bh\/Content\/Files\/Publications\/GCC%20Cancer%20Incidence%202011.pdfSeptember12011"},{"key":"key20200713202436_b4-mco-0-0-1850","unstructured":"Cancer Incidence Report Saudi Arabia 2013http:\/\/www.chs.gov.sa\/Ar\/HealthCenters\/NCC\/CancerRegistry\/CancerRegistryReports\/2013June12016"},{"key":"key20200713202436_b5-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"736261","DOI":"10.1155\/2011\/736261","article-title":"Clinical, molecular, and environmental risk factors for Hodgkin lymphoma","volume":"2011","author":"Maggioncalda","year":"2011","journal-title":"Adv Hematol"},{"key":"key20200713202436_b6-mco-0-0-1850","first-page":"617","article-title":"The changing trends of adult Hodgkin's disease in Saudi Arabia","volume":"24","author":"Al-Diab","year":"2003","journal-title":"Saudi Med J"},{"key":"key20200713202436_b7-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"920898","DOI":"10.1155\/2011\/920898","article-title":"Pathobiology of hodgkin lymphoma","volume":"2011","author":"Piccaluga","year":"2011","journal-title":"Adv Hematol"},{"key":"key20200713202436_b8-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"142395","DOI":"10.1155\/2011\/142395","article-title":"Hodgkin's lymphomas: A tumor recognized by its microenvironment","volume":"2011","author":"Montes-Moreno","year":"2011","journal-title":"Adv Hematol"},{"key":"key20200713202436_b9-mco-0-0-1850","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.5858\/2010-0207-OA.1","article-title":"Nodular lymphocyte predominant Hodgkin lymphoma: Diagnostic pearls and pitfalls","volume":"134","author":"Smith","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"key20200713202436_b10-mco-0-0-1850","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"key20200713202436_b11-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International prognostic factors project on advanced Hodgkin's disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"key20200713202436_b12-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"e6341","DOI":"10.1371\/journal.pone.0006341","article-title":"Prognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: A study of 59 cases","volume":"4","author":"Canioni","year":"2009","journal-title":"PLoS One"},{"key":"key20200713202436_b13-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1200\/JCO.2011.41.0910","article-title":"International prognostic score in advanced-stage Hodgkin's lymphoma: Altered utility in the modern era","volume":"30","author":"Moccia","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20200713202436_b14-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7326\/0003-4819-114-5-361","article-title":"Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC lymphoma cooperative group","volume":"114","author":"Henry-Amar","year":"1991","journal-title":"Ann Intern Med"},{"key":"key20200713202436_b15-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"387034","DOI":"10.1155\/2011\/387034","article-title":"Flow cytometric detection of the classical hodgkin lymphoma: Clinical and research applications","volume":"2011","author":"Roshal","year":"2011","journal-title":"Adv Hematol"},{"key":"key20200713202436_b16-mco-0-0-1850","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.5858\/2004-128-1004-AOFCAI","article-title":"Applications of flow cytometry and immunohistochemistry to diagnostic hematopathology","volume":"128","author":"Dunphy","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"key20200713202436_b17-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/asheducation-2014.1.144","article-title":"The classical Hodgkin lymphoma tumor microenvironment: Macrophages and gene expression-based modeling","volume":"2014","author":"Scott","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20200713202436_b18-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: A correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan","year":"2012","journal-title":"Blood"},{"key":"key20200713202436_b19-mco-0-0-1850","first-page":"765","article-title":"Macrophages in human cancer: Current and future aspects","volume":"16","author":"Mallmann","year":"2012","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"key20200713202436_b20-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nm0810-861","article-title":"A double agent in cancer: Deciphering macrophage roles in human tumors","volume":"16","author":"Ruhrberg","year":"2010","journal-title":"Nat Med"},{"key":"key20200713202436_b21-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/1097-0142(19850715)56:2<333::AID-CNCR2820560222>3.0.CO;2-0","article-title":"Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease","volume":"56","author":"Ree","year":"1985","journal-title":"Cancer"},{"key":"key20200713202436_b22-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12916-016-0711-6","article-title":"Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma","volume":"14","author":"Guo","year":"2016","journal-title":"BMC Med"},{"key":"key20200713202436_b23-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1200\/JCO.2016.70.9709","article-title":"Risk of second cancer in Hodgkin lymphoma survivors and influence of family history","volume":"35","author":"Sud","year":"2017","journal-title":"J Clin Oncol"},{"key":"key20200713202436_b24-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"key":"key20200713202436_b25-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1182\/blood-2010-02-270009","article-title":"A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma","volume":"116","author":"S\u00e1nchez-Espiridi\u00f3n","year":"2010","journal-title":"Blood"},{"key":"key20200713202436_b26-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","article-title":"Tumor-associated neutrophils: New targets for cancer therapy","volume":"71","author":"Gregory","year":"2011","journal-title":"Cancer Res"},{"key":"key20200713202436_b27-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/jnci\/90.21.1583","article-title":"Tumor-associated macrophages as target for cancer therapy","volume":"90","author":"Wahl","year":"1998","journal-title":"J Natl Cncer Inst"},{"key":"key20200713202436_b28-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/gm240","article-title":"Predicting treatment outcome in classical Hodgkin lymphoma: Genomic advances","volume":"3","author":"Derenzini","year":"2011","journal-title":"Genome Med"},{"key":"key20200713202436_b29-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"e0124531","DOI":"10.1371\/journal.pone.0124531","article-title":"Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival","volume":"10","author":"Barros","year":"2015","journal-title":"PLoS One"},{"key":"key20200713202436_b30-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1600-0609.2011.01731.x","article-title":"CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma","volume":"88","author":"Yoon","year":"2012","journal-title":"Eur J Haematol"},{"key":"key20200713202436_b31-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/annonc\/mdr157","article-title":"Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma","volume":"23","author":"Azambuja","year":"2012","journal-title":"Ann Oncol"},{"key":"key20200713202436_b32-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1309\/QHD6YFN81KQXUUH6","article-title":"CD163: A specific marker of macrophages in paraffin-embedded tissue samples","volume":"122","author":"Lau","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"key20200713202436_b33-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000028105","article-title":"The scavenger receptor CD163: Regulation, promoter structure and genomic organization","volume":"67","author":"Ritter","year":"1999","journal-title":"Pathobiology"},{"key":"key20200713202436_b34-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1746-1596-7-12","article-title":"CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma","volume":"7","author":"Harris","year":"2012","journal-title":"Diagn Pathol"},{"key":"key20200713202436_b35-mco-0-0-1850","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/cncr.24205","article-title":"Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk","volume":"115","author":"El-Zein","year":"2009","journal-title":"Cancer"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T18:53:39Z","timestamp":1663354419000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2019.1850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":35,"URL":"https:\/\/doi.org\/10.3892\/mco.2019.1850","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]}}}